oxazolidin-2-one has been researched along with Diathesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birket, SE; Breslow-Deckman, JM; Feola, DJ; Garvy, BA; Ho, TN; Hoskins, SN; Mattingly, CM | 1 |
| Alvarez, F; Cereijo, E; Latorre, MM; Martínez, H; Oltra, R; Rodríguez, O | 1 |
| Freeman, AF; Harrington, SM; Holland, SM; Murray, PR; Roberts, SM; Zelazny, AM | 1 |
| Huang, J; Malczynski, M; Noskin, GA; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, TR | 1 |
4 other study(ies) available for oxazolidin-2-one and Diathesis
| Article | Year |
|---|---|
Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; CD4 Lymphocyte Count; Coinfection; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Influenza A virus; Interferon-gamma; Linezolid; Lung; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oxazolidinones; Pneumonia, Pneumococcal; Recombinant Proteins; Tumor Necrosis Factor-alpha; Viral Load; Virus Replication | 2013 |
Use of linezolid in critically ill patients admitted to intensive care units.
Topics: Acetamides; Anti-Bacterial Agents; Catheter-Related Infections; Community-Acquired Infections; Critical Care; Critical Illness; Cross Infection; Disease Susceptibility; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Prospective Studies; Staphylococcal Infections; Thrombocytopenia; Treatment Outcome | 2009 |
Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy.
Topics: Acetamides; Adolescent; Child; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Follow-Up Studies; Humans; Immunocompromised Host; Job Syndrome; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Risk Assessment; Siblings; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2006 |
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Topics: Academic Medical Centers; Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |